Study of Microsatellite Instability by Immunohistochemistry in a Cohort of Patients With Melanoma
Journal of Cutaneous Pathology · 2025
DOI: 10.1111/cup.14758 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Cutaneous Pathology, 2025. Verfasst von Rodolfo David Palacios Diaz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain. Hauptthemen laut MEDLINE: Melanoma, Microsatellite Instability, Immunohistochemistry, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
Background
Microsatellite instability (MSI) has prognostic value and impacts therapy strategies in several malignancies. Data regarding MSI in melanoma are scarce. The aim of this study was to assess MSI through the analysis of MMR protein expression in patients with melanoma.
Methods
An observational retrospective single‐center study was designed based on patients with primary melanoma. We assessed MSI through immunohistochemical staining with anti‐MLH1, anti‐MSH2, anti‐MSH6, and anti‐PMS2 on full–thickness excision tissue.
Results
Ninety‐three patients were included in this study. The complete absence of nuclear staining in tumoral cells was extremely rare, with only one melanoma not expressing MSH6. Most melanomas showed an expression index for MLH1 (77.7%), MSH2 (87.2%), and PMS2 (78.6%) ≥ 75%. Most melanomas (57.8%) exhibited an MSH6 expression index in the range of 1%–74%. A low MSH6 expression index and a reduced combined MMR protein expression index (MMR‐e) were significantly associated with higher melanoma‐specific survival. A mild PMS2 staining intensity was significantly associated with a higher melanoma‐specific survival. The patients with high MMR‐e who received immunotherapy progressed and died more frequently than those with reduced MMR‐e (75% vs. 33.3%).
Conclusion
More studies are needed to further define the role of MSI in melanoma prognosis and response to immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
- Dermatology, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
- Pathology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
- Molecular Biology Laboratory, Service of Clinical Analysis, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
- Department of Medicine, Universitat de València, Valencia, Spain.
ORCID-Profile: Rodolfo David Palacios Diaz, Blanca de Unamuno Bustos, Rafael Botella Estrada
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Palacios Diaz, R. D., de Unamuno Bustos, B., Pozuelo Ruiz, M., Llavador Ros, M., Palanca Suela, S., & Botella Estrada, R. (2025). Study of Microsatellite Instability by Immunohistochemistry in a Cohort of Patients With Melanoma. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14758
Vancouver
Palacios Diaz RD, de Unamuno Bustos B, Pozuelo Ruiz M, Llavador Ros M, Palanca Suela S, Botella Estrada R. Study of Microsatellite Instability by Immunohistochemistry in a Cohort of Patients With Melanoma. Journal of Cutaneous Pathology. 2025. doi:10.1111/cup.14758
BibTeX
@article{PalaciosDiaz2025,
author = {Palacios Diaz, Rodolfo David and de Unamuno Bustos, Blanca and Pozuelo Ruiz, Mónica and Llavador Ros, Margarita and Palanca Suela, Sarai and Botella Estrada, Rafael},
title = {Study of Microsatellite Instability by Immunohistochemistry in a Cohort of Patients With Melanoma},
journal = {Journal of Cutaneous Pathology},
year = {2025},
doi = {10.1111/cup.14758}
}
EUVIMED